Real-time in situ detection of active proteases is crucial for early-stage cancer screening and cell signaling pathway study; however, it is difficult to achieve using fluorescence or radioactive probes at volumes below 1nL. Here we demonstrated a hybrid optical probe by incorporating nanocrescent particle and peptides with artificial tag molecules. We performed a proof-of-concept study using prostate specific antigen (PSA), one of the most prominent prostate cancer markers, and a serine protease present in patients' seminal fluid and serum. The Raman spectral signal from the tag molecules is enhanced by the nanocrescent and the signal is monitored as the indicator for peptide cleavage in a femtoliter reaction volume, at levels close to a single proteolytically active PSA molecule.
Prostate cancer is the most common cancer in men in Europe and North America [1] [2] [3] . One of the clinical diagnosis tools for prostate cancer is the measurement of plasma protein concentration of the prostate-specific antigen (PSA or hK3), which is a member of the large kallikrein (hK) protease family (for reviews, see [4] [5] [6] ) normally secreted from prostate luminal epithelial cells. Unlike other kallikrein family members, PSA is a chymotrypsin-like serine protease 7 . In prostate cancer, PSA, aided by the proteolytic activity, is involved in tissue remodeling against the extracellular matrix, contributing critical control mechanisms to tumor invasion or progression.
The introduction of plasma PSA screening since the 1980s has greatly improved the diagnosis, staging, and management of prostate cancer 5 ; however, measurement of plasma PSA concentration does not differentiate the prostate cancer patients from those with benign prostatic hyperplasia, leading to a high false positive rate, requirement for more expensive biopsies, and even unnecessary surgical procedures 5, 6 . Efforts to enhance the clinical value of the PSA for early detection of prostate cancer have included the characterization of various molecular isoforms of PSA [8] [9] [10] . Among those various isoforms, the proteolytically active subpopulation of PSA is accepted as a more useful tumor marker and malignancy predictor than the serum PSA concentration 11, 12 . Simple detection of the presence of PSA by a traditional immunostaining method can not reveal the proteolytic activity of PSA; therefore, it is of great importance to develop new methods to discriminate the proteolytically active isoform. Seminal fluid has been demonstrated to carry an abundance of proteolytically active PSA and is a biological source of PSA for protease activity assays 13, 14 . The concentration of proteolytically active PSA in seminal fluid is at 10-150 µM 14 , while its concentration in the plasma is much lower, from less than 0.1nM in healthy individuals to higher than 1nM in patients with prostate disease 15 . However, an assay that measures the proteolytic activity of PSA in seminal fluid or biopsy samples from fine needle aspiration is still not widely accepted, due to the quick decay of the proteolytic activity, and the limited amount of seminal fluid available from old patients or biopsy samples.
The sensitivity of current detection methods reaches subnanomolar concentrations for PSA protein [16] [17] [18] (mostly determined by the binding affinity of the antibody to PSA), and relatively large sample volume (milliliter) is required. However, the enzymatic assays have not enjoyed the same sensitivity enhancement. Here we introduce a new optical spectroscopic detection method for PSA proteolytic activity based on a Raman tagged PSA specific substrate peptide 7, [12] [13] [14] 19 conjugated on crescent-shaped nanoparticles, which can be used on minute sample volumes (femtoliters), integrated into microfluidics, or introduced intracellularly, and be used to optically monitor PSA proteolytic reactions in real time.
Other proteases play similar roles in cancers as well, thus this proof-of-concept nanoprobe has the potential to be further refined and improved to be used as a general measurement tool for other proteases in cancer. 20, [22] [23] [24] [25] . The nanoscale dimension and the high local electromagnetic field enhancement of our nanocrescent SERS substrate enable a high-sensitivity optical detection of biomolecular reactions on its surface (Figure 1c ).
Materials and Methods

PSA preparation
PSA was purchased from CalBiochem (San Diego, CA). Cleavage of the substrate peptide immobilized on the Au nanocrescent was performed in buffer of 50mM Tris-HCl, pH 8.0, 100mM
NaCl, and 0.1mM EDTA, and the reaction was monitored in real-time in 37 o C. PSA inhibitor was .
R19-Ava-HSSKLQLAAAC-NH 2 (2)
. 401 mg (0.277 mmol) of Rink Amide AM polystyrene resin (loading 0.69 mmol/ g) was added to a 12 mL fritted syringe and swollen with N-methylpyrrolidinone (NMP) (4 mL). The Fmoc protecting group was removed by treatment with 1:2:2 piperidine/NMP/CH 2 Cl 2 solution (3 mL) for 30 min, and the resin was filtered and washed with NMP (3 x 3 mL) and CH 2 Cl 2 (3 x 3 mL). To load the α-amino acid residues, the resin was subjected to repeated cycles of coupling conditions (method A or method B), followed by washing (5 x 3 mL NMP, 5 x 3 mL 
SERS Spectroscopy
A microscopy system with Raman spectrometer was used to acquire Raman scattering spectra from single nanocrescents. The system consisted of a Carl Zeiss Axiovert 200 inverted microscope (Carl Zeiss, Germany) equipped with a digital camera and a 300 mm focal-length monochromator (Acton Research, MA) with a 1024 × 256-pixel cooled spectrograph CCD camera (Roper Scientific, NJ). A 9 and the laser beam was focused by a 40X objective lens on the nanocrescent. The excitation power was measured by a photometer (Newport, CA) to be ~0.8 mW. The Raman scattering light was then collected through the same optical pathway through a long-pass filter and analyzed by the spectrometer.
RESULTS
The nanocrescents consist of a 100 nm polystyrene core and a 10~20 nm gold crescent shell. Fig. 1a shows the schematics and transmission electron micrograph of the nanocrescent. The nanocrescents are fabricated by angled Au deposition on the rotating polystyrene nanoparticle template 20 . The fabrication details were described previously 20 . In this paper, the polystyrene nanoparticle core is not removed and it serves as the internal control in the SERS detections. We then tether on the surface of the Au nanocrescent a substrate peptide that can be specifically cleaved by proteolytically active PSA. The peptides contain the sequence of HSSKLQLAAAC which has been shown to have very high specificity for proteolytically active PSA 26 . It has been shown that HSSKLQ-L is cleaved by PSA but not by any other proteases in vivo in a mouse model 27 . A cysteine group at the carboxyl terminus of the peptide is used to attach the peptide to the Au surface, relying on the Au-thiol reaction to form a covalent bond.
At the amino terminus of the peptide, Raman active molecules such as biotin (Fig. 1a) or Rhodamine 6G (R19) (Fig. 1b) are grafted through a short polyethyleneglycol or aminovaleric acid linker. The detection scheme is shown in Fig. 1b . The SERS spectra of the artificial peptides change after cleavage by PSA, and the characteristic SERS peaks of the molecular moieties with the biotin or R19 tags disappear due to the diffusive dislocation of the tag molecules from the nanocrescent surface into the solution after peptide digestion; therefore the existence and concentration of the proteolytically active PSA in solution can be probed by monitoring the SERS spectra of the peptide-conjugated nanocrescents. The Raman scattering signal of the attached peptide is amplified by the nanocrescent.
Our numerical simulation (Fig. 1c) indicates the amplitude of the local electric field can be enhanced by close to 20 dB (100 fold) especially around the sharp edge. Due to the fourth power relation between the electric field amplitude and the Raman enhancement factor, the peptide Raman signal could be amplified 10 8 times by the nanocrescent. The typical SERS spectra of the peptide-conjugated nanocrescents with biotin and R19 Raman tag molecules are shown in fig. 3a and 3b, respectively. By comparing the SERS spectra before and 2 hours after the peptide digestion experiments, the Raman peaks from the polystyrene core, e.g. 1003 cm -1 , remains constant, which serves as an internal control. Some Raman peaks are from the partial amino acid chain remaining on the nanocrescent surface after digestion and they still appear in the spectra, although the peak positions have slight changes and the peak intensities decrease due to possible conformational changes upon peptide cleavage. Those peaks from the Raman tag molecules, such as 525 cm -1 from biotin in fig. 3a and 1183 cm -1 from R19 in fig. 3b , almost completely disappear after the digestion reaction is finished (Fig. 3) .
The digestion reaction dynamics can be monitored by time-resolved SERS spectra acquisitions.
Because ~100 peptides are used in conjugation reaction for each nanocrescent on average, the disappearance of the characteristic Raman peaks from the tag molecules is not abrupt. Since most of the enhanced field is concentrated around the tip area, which accounts for ~1/6 of total area of the nanocrescent, the actual molecule number contributing to the Raman scattering signal in this high enhancement area is less than 20, even if assuming the conjugation efficiency is 100% (Fig. 1d) . As shown in the time-lapse SERS spectra in Fig. 3a , the digestion of the peptides on each nanocrescent, as monitored by the disappearance of the biotin peak at 525 cm -1 , takes ~30 min at a PSA concentration of 420 nM. For the peptide with R19 as the Raman tag molecule, the disappearance of the R19 peak at 1183 cm -1 can be also observed after digestion by 420 nM PSA (Fig. 3b) . These changes can be tracked with real-time monitoring of the SERS spectra, as depicted in Fig. 4 .
In order to specifically inhibit the PSA-mediated proteolysis of the conjugated peptides, protease inhibitors were introduced prior to the addition of 420 nM PSA. We also tested the specificity of the conjugated peptides to PSA using other serine proteases such as Granzyme B, which serves as a negative control here. Fig. 5b shows the time-lapse SERS spectra measurement of nanocrescents with R19 tag molecules in the above two control experiments with the PSA inhibitor and the serine protease Granzyme B, which has orthogonal substrate specificity to PSA, respectively. The peptide digestion by PSA is more than 90% suppressed after the addition of inhibitors given the same experimental conditions. In the control experiment of peptide digestion by 420 nM Granzyme B, the reaction rate showed no statistically significant difference from the inhibitor-treated reaction. The inability for Granzyme B to cleave the peptide is also expected as PSA has been shown to be the only protease for the HSSKLQ sequence in vivo 27 .
The digestion rate is related to the PSA concentration (Fig. 5 ) and we observed PSA activity in 30 min for a concentration way below 1nM (data not shown). Since at most 100 peptide molecules are attached per nanocrescent, it is likely that the nanocrescent surface with the highest SERS signal is not fully taken advantage of, and only a small percentage of the peptides are attached to the region that provides the greatest enhancement in electromagnetic field (Fig. 1c) . Fig. 5a shows the intensities of the biotin cleaved by PSA and the enzyme concentration, specificity and inhibition can be differentiated from the observed reaction rates with high statistical significance; therefore this peptide-conjugated nanocrescent can be used as a specific screening tool to provide information on the concentration and proteolytic activity of the cancer biomarker PSA.
DISCUSSION
In conclusion, we have demonstrated the in vitro detection of proteolytically active PSA using a single peptide-conjugate nanocrescent SERS probe with at least nanomolar sensitivity. We used a highly We can easily envision that semen can be diluted 1000 times before we take an accurate and quantitative protease measurement. Due to the lack of active PSA in serum, this assay will not be useful for detection of PSA protease activity in the plasma. However, as mentioned above, circulating prostate cancer cells, if captured using surface markers, will secrete active PSA, and the concentration range has been suggested to be in mid nanomolar range, as observed in xenograft mouse models 26, 27 . Our assay will be suitable for this situation. In the current generation design, the PSA digestion site is between and the Glutamine (Q) and Leucine (L) residues, and is very close to the Au surface, thus the PSA peptide could be sterically hindered from the PSA enzyme and not optimally accessible. We envision that, with an additional spacer synthesized in between the substrate peptide sequence HSSKLQ-L and the Cys residue, we can improve the presentation of PSA substrate peptide HSSKLQ-L on the surface and thereby increase the detection sensitivity. The real-time reaction monitoring also provides critical information on PSA activity rather than just measuring the presence of the protein. Given the spectroscopic detection system with higher sensitivity, the reaction dynamics can be tracked at higher temporal resolution and the single event of proteolysis event can be possibly visualized. Two different Raman tag molecules are successfully utilized here indicating the potential of multiplexing the peptideconjugated nanocrescents to detect two or more types of cancer-related proteases. The core can be made of magnetic material to allow spatial addressing of individual nanoparticles 28 . The nanocrescent can also be manipulated by laser to address at high accuracy spatially 29 , so that it could be multiplexed as high density arrays (with sub-microliter volume). Additional spatial multiplexing for multiple proteases in a microarray or nanoarray format is under investigation in our laboratories. In addition, the magnetic or laser maneuverability allow biosensing at desired locations 28 , which would be useful for obtaining in situ measurements intracellularly. The sub-milliwatt laser excitation power and near infrared wavelength can prevent tissue damages in future living cell imaging experiments. 
